Inspire Medical Systems, Inc.

Total Valuation

Inspire Medical Systems, Inc. carries a market capitalization of 1.35B, placing it among publicly traded companies globally. Its enterprise value stands at 1.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Inspire Medical Systems, Inc. currently has 28.80M shares outstanding.

Valuation Ratios

Inspire Medical Systems, Inc. trades at a trailing price-to-earnings ratio of 11.45. The price-to-sales ratio is 1.64, and the price-to-book ratio stands at -9.52.

Enterprise Valuation

On an enterprise value basis, Inspire Medical Systems, Inc. trades at an EV/EBITDA multiple of 18.53 and an EV/FCF ratio of 7.48. The EV/Sales ratio of 1.36 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.31 provides insight into valuation relative to core operating earnings.

Financial Position

Inspire Medical Systems, Inc. maintains a current ratio of 6.34, meaning it holds 6.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.73, indicating elevated leverage, while an interest coverage ratio of 491.56 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Inspire Medical Systems, Inc. has paid -67.20M in income taxes, reflecting an effective tax rate of 597.88.

Stock Price Statistics

Inspire Medical Systems, Inc.'s stock has declined approximately -63.00528% over the past 52 weeks. The 50-day moving average sits at 45.20, while the 200-day moving average is 71.44.

Income Statement

Over the trailing twelve months, Inspire Medical Systems, Inc. generated 915.25M in revenue and converted that into 131.14M in net income, yielding earnings per share of 4.48. EBITDA reached 67.34M, while operating income came in at 51.32M.

Balance Sheet

Inspire Medical Systems, Inc. holds 283.83M in cash and equivalents against 29.55M in total debt, resulting in a net debt position of -98.93M. Total book value stands at -157.76M, with working capital of 477.40M providing operational flexibility.

Cash Flow

Inspire Medical Systems, Inc. produced 136.53M in operating cash flow over the past twelve months. After subtracting -30.09M in capital expenditures, free cash flow totaled 106.44M - equivalent to 3.66 per share.

Margins

Inspire Medical Systems, Inc. operates with a gross margin of 85.78, reflecting its pricing power and cost economics. The operating margin of 5.61 and net profit margin of 14.33 provide insight into operational efficiency.

Dividends & Yields

Scores

Inspire Medical Systems, Inc. posts an Altman Z-Score of 9.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.